Comparison of hospital length of stay in patients treated with non–vitamin K oral anticoagulants or parenteral agents plus warfarin for venous thromboembolism
Objectives: Existing research comparing hospital length of stay for patients treated with non–vitamin K oral anticoagulants or parenteral bridging to warfarin has been conducted primarily with the agent rivaroxaban. The objective of this study was to compare hospital length of stay between patients...
Main Authors: | Catherine A Saint, Michelle R Castelli, Andrew J Crannage, Zachary A Stacy, Erin K Hennessey |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-07-01
|
Series: | SAGE Open Medicine |
Online Access: | https://doi.org/10.1177/2050312117719628 |
Similar Items
-
Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism
by: Adiguzel Cafer, et al.
Published: (2011-03-01) -
Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017
by: Pamela L. Lutsey, et al.
Published: (2019-10-01) -
Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.
by: Thomas Hendriks, et al.
Published: (2020-01-01) -
ADVANTAGES AND DISADVANTAGES OF WARFARIN AND PRADAXA THERAPY FOR VENOUS THROMBOEMBOLISM
by: B. S. Sukovatykh, et al.
Published: (2018-01-01) -
Efficacy and safety of warfarin treatment in venous thromboembolic disease
by: Sandén, Per
Published: (2017)